BRED participated in the 22nd China International Exhibition of Clinical Laboratory Medicine and IVD (CACLP)
March 25, 2025
The 22nd China International Exhibition of Clinical Laboratory Medicine and IVD (CACLP) was successfully held from March 21 to 24, 2025, at the Hangzhou Grand Convention and Exhibition Center. The theme of this experimental medicine and in vitro diagnostics (IVD) event was "The Power of Innovation for a Healthy IVD Industry."
BRED participated in the exhibition, showcasing its latest four diagnostic platforms, including the fully automated seminal plasma biochemical immunoanalyzer, fully automated chemiluminescence analyzer, and sperm function flow cytometry system. Key products such as the Sperm-Hyaluronic Acid Binding Assay Kit and Live Sperm DNA Fragmentation Test garnered significant attention from experts and industry professionals. Notably, the event attracted not only domestic visitors but also a substantial number of international attendees, who expressed strong interest in BRED's innovations.